Global Viral Vector and Plasmid DNA Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028


Published on: 2022-01-21 | No of Pages : 323 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Viral Vector and Plasmid DNA Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Executive Summary

According to GRD Survey data, the global Viral Vector and Plasmid DNA market is estimated at 670 million US$ in 2021 and is expected to 2670 million US$ by the end of 2028, growing at a CAGR of 21.9% in the forecast period from 2022 to 2028.

This report studies the Viral Vector and Plasmid DNA market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Viral Vector and Plasmid DNA in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Plasmid DNA
Viral Vector

Market Snapshot, By Application
Cancer
Virus Infection
Hereditary Disease

Main Market Players Analyzed in this report, including:
Yposkesi
VGXI
UniQure
Richter-Helm
PlasmidFactory
Oxford BioMedica
OBiO Technology
MolMed
MassBiologics
Lonza
Jikai Gene
Gene Synthesis
FUJIFILM Diosynth Biotechnologies
FinVector
Eurogentec
Cobra Biologics
Cell and Gene Therapy Catapult
Brammer Bio
Biovian
BioReliance
Aldevron

The study objectives of this report are:
To study and analyze the global Viral Vector and Plasmid DNA market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Viral Vector and Plasmid DNA market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Viral Vector and Plasmid DNA manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Viral Vector and Plasmid DNA market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Viral Vector and Plasmid DNA submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Viral Vector and Plasmid DNA are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Viral Vector and Plasmid DNA Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Viral Vector and Plasmid DNA Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Viral Vector and Plasmid DNA

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Cancer
3.2.2 Major Buyers in Virus Infection

4 Market Segment: by Type
4.1 Viral Vector and Plasmid DNA Type Introduction
4.1.1 Plasmid DNA
4.1.2 Viral Vector
4.2 Global Viral Vector and Plasmid DNA Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Viral Vector and Plasmid DNA Type Introduction
5.1.1 Cancer
5.1.2 Virus Infection
5.1.3 Hereditary Disease
5.2 Global Viral Vector and Plasmid DNA Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Viral Vector and Plasmid DNA Market by Region
6.2 North America Viral Vector and Plasmid DNA Market 2016-2021
6.3 Europe Viral Vector and Plasmid DNA Market 2016-2021
6.4 Asia Pacific Viral Vector and Plasmid DNA Market 2016-2021
6.5 South America Viral Vector and Plasmid DNA Market 2016-2021
6.6 Middle East and Africa Viral Vector and Plasmid DNA Market 2016-2021

7 North America
7.1 North America Viral Vector and Plasmid DNA Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Viral Vector and Plasmid DNA Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Viral Vector and Plasmid DNA Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Viral Vector and Plasmid DNA Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Viral Vector and Plasmid DNA Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Yposkesi
12.1.1 Yposkesi Company Information
12.1.2 Yposkesi Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.1.3 Yposkesi Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.1.4 Yposkesi Key Development
12.2 VGXI
12.2.1 VGXI Company Information
12.2.2 VGXI Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.2.3 VGXI Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.2.4 VGXI Key Development
12.3 UniQure
12.3.1 UniQure Company Information
12.3.2 UniQure Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.3.3 UniQure Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.3.4 UniQure Key Development
12.4 Richter-Helm
12.4.1 Richter-Helm Company Information
12.4.2 Richter-Helm Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.4.3 Richter-Helm Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.4.4 Richter-Helm Key Development
12.5 PlasmidFactory
12.5.1 PlasmidFactory Company Information
12.5.2 PlasmidFactory Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.5.3 PlasmidFactory Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.5.4 PlasmidFactory Key Development
12.6 Oxford BioMedica
12.6.1 Oxford BioMedica Company Information
12.6.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.6.3 Oxford BioMedica Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.6.4 Oxford BioMedica Key Development
12.7 OBiO Technology
12.7.1 OBiO Technology Company Information
12.7.2 OBiO Technology Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.7.3 OBiO Technology Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.7.4 Oxford BioMedica Key Development
12.9 MassBiologics
12.9.1 MassBiologics Company Information
12.9.2 MassBiologics Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.9.3 MassBiologics Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.9.4 MassBiologics Key Development
12.8 MolMed
12.8.1 MolMed Company Information
12.8.2 MolMed Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.8.3 MolMed Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.8.4 MolMed Key Development
12.11 Jikai Gene
12.11.1 Jikai Gene Company Information
12.11.2 Jikai Gene Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.11.3 Jikai Gene Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.11.4 Jikai Gene Key Development
12.12 Gene Synthesis
12.12.1 Gene Synthesis Company Information
12.12.2 Gene Synthesis Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.12.3 Gene Synthesis Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.12.4 Gene Synthesis Key Development
12.13 FUJIFILM Diosynth Biotechnologies
12.13.1 FUJIFILM Diosynth Biotechnologies Company Information
12.13.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.13.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.13.4 FUJIFILM Diosynth Biotechnologies Key Development
12.14 FinVector
12.14.1 FinVector Company Information
12.14.2 FinVector Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.14.3 FinVector Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.14.4 FinVector Key Development
12.15 Eurogentec
12.15.1 Eurogentec Company Information
12.15.2 Eurogentec Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
12.15.3 Eurogentec Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
12.15.4 Eurogentec Key Development
12.17 Cell and Gene Therapy Catapult
12.18 Brammer Bio
12.19 Biovian
12.20 BioReliance
12.21 Aldevron

13 Global Viral Vector and Plasmid DNA Market Forecast by Region by Type and by Application
13.1 Global Viral Vector and Plasmid DNA Revenue Forecast 2022-2027
13.2 Global Viral Vector and Plasmid DNA Forecast by Regions
13.3 Global Viral Vector and Plasmid DNA Forecast by Type
13.4 Global Viral Vector and Plasmid DNA Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Viral Vector and Plasmid DNA Production Specifications
Table 2: Drivers in Viral Vector and Plasmid DNA Market
Table 3: Restraints Viral Vector and Plasmid DNA Market
Table 4: Opportunity in Viral Vector and Plasmid DNA Market
Table 5: Comparion of Alternative and Viral Vector and Plasmid DNA
Table 6: Viral Vector and Plasmid DNA Raw Materials Key Suppliers List
Table 7: Viral Vector and Plasmid DNA Distributors List
Table 8: Viral Vector and Plasmid DNA Major Buyers in Application One
Table 9: Viral Vector and Plasmid DNA Major Buyers in Application Two
Table 10: Viral Vector and Plasmid DNA Major Buyers in Application Three
Table 11: Global Viral Vector and Plasmid DNA Revenue (Million USD) by Type 2016-2021
Table 12: Global Viral Vector and Plasmid DNA Revenue Market Share by Type 2016-2021
Table 18: Global Viral Vector and Plasmid DNA Revenue (Million USD) by Application 2016-2021
Table 19: Global Viral Vector and Plasmid DNA Revenue Market Share by Application 2016-2021
Table 20: Global Viral Vector and Plasmid DNA Revenue (Million USD) by Region 2016-2021
Table 21: Global Viral Vector and Plasmid DNA Revenue Market Share by Region 2016-2021
Table 22: North America Viral Vector and Plasmid DNA Revenue (Million USD) by Country 2016-2021
Table 23: North America Viral Vector and Plasmid DNA Revenue Market Share by Country 2016-2021)
Table 24: Europe Viral Vector and Plasmid DNA Revenue (Million USD) by Country 2016-2021
Table 25: Europe Viral Vector and Plasmid DNA Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Viral Vector and Plasmid DNA Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Viral Vector and Plasmid DNA Revenue Market Share by Country 2016-2021)
Table 28: South America Viral Vector and Plasmid DNA Revenue (Million USD) by Country 2016-2021
Table 29: South America Viral Vector and Plasmid DNA Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Viral Vector and Plasmid DNA Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Viral Vector and Plasmid DNA Revenue Market Share by Country 2016-2021)
Table 32 Yposkesi Company Information
Table 33 Yposkesi Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 34 Yposkesi Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 35 VGXI Company Information
Table 36 VGXI Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 37 VGXI Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 38 UniQure Company Information
Table 39 UniQure Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 40 UniQure Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 41 Richter-Helm Company Information
Table 42 Richter-Helm Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 43 Richter-Helm Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 44 PlasmidFactory Company Information
Table 45 PlasmidFactory Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 46 PlasmidFactory Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 47 Oxford BioMedica Company Information
Table 48 Oxford BioMedica Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 49 Oxford BioMedica Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 50 OBiO Technology Company Information
Table 51 OBiO Technology Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 52 OBiO Technology Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 53 MolMed Company Information
Table 54 MolMed Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 55 MolMed Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 56 MassBiologics Company Information
Table 57 MassBiologics Viral Vector and Plasmid DNA Product Portfolio, Specification and Application
Table 58 MassBiologics Viral Vector and Plasmid DNA Revenue and Gross Margin (2019-2021)
Table 59: Global Viral Vector and Plasmid DNA Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Viral Vector and Plasmid DNA Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Viral Vector and Plasmid DNA Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Viral Vector and Plasmid DNA Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Viral Vector and Plasmid DNA Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Viral Vector and Plasmid DNA Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Viral Vector and Plasmid DNA Picture
Figure 2: Global Viral Vector and Plasmid DNA Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Viral Vector and Plasmid DNA Industry Life Cycle
Figure 5: Product Picture of Plasmid DNA
Figure 6: Product Picture of Viral Vector
Figure 9: Global Viral Vector and Plasmid DNA Revenue Market Share by Type, 2020
Figure 10: Viral Vector and Plasmid DNA in Cancer
Figure 11: Global Viral Vector and Plasmid DNA Market: Cancer 2016-2021
Figure 12: Viral Vector and Plasmid DNA in Virus Infection
Figure 13: Global Viral Vector and Plasmid DNA Market: Virus Infection 2016-2021
Figure 14: Global Viral Vector and Plasmid DNA Revenue Market Share by Application, 2020
Figure 15: Global Viral Vector and Plasmid DNA Revenue Market Share by Region 2016-2021
Figure 16: North America Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 7: Europe Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 8: Asia Pacific Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 9: South America Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 10: Middle East and Africa Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 11: North America Viral Vector and Plasmid DNA Revenue Market Share by Country, 2020
Figure 12: United States Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 13: Canada Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 14: Mexico Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 15: Europe Viral Vector and Plasmid DNA Revenue Market Share by Country, 2020
Figure 16: Germany Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 17: France Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 18: UK Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 19: Italy Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 20: Russia Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 21: Spain Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Viral Vector and Plasmid DNA Revenue Market Share by Country, 2020
Figure 23: China Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 24: Japan Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 25: Korea Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 26: Southeast Asia Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 27: India Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 28: Australia Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 29: South America Viral Vector and Plasmid DNA Revenue Market Share by Country, 2020
Figure 30: Brazil Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 31: Argentina Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 32: Colombia Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 33: Middle East and Africa Viral Vector and Plasmid DNA Revenue Market Share by Country, 2020
Figure 34: Turkey Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 35: Saudi Arabia Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 36: South Africa Viral Vector and Plasmid DNA Revenue (Million USD) Status 2016-2021
Figure 37: Yposkesi Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 38: VGXI Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 39: UniQure Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 40: Richter-Helm Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 41: PlasmidFactory Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 42: Oxford BioMedica Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 43: OBiO Technology Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 44: MolMed Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 45: MassBiologics Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 46: Lonza Viral Vector and Plasmid DNA Revenue Market Share Globally (2019-2021)
Figure 47: Global Viral Vector and Plasmid DNA Revenue (Million USD) Forecast (2022-2027)